Cellular and T cell engager Immunotherapy
Talquetamab vs Real-World Physician’s Choice in Patients With Relapsed/Refractory Multiple Myeloma and Prior B-Cell Maturation Antigen Therapy: Analyses of MonumenTAL-1 vs LocoMMotion/MoMMent
María-Victoria Mateos, MD, PhD
Professor
University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
Salamanca, Spain